Tesamorlin is a synthetically produced peptide derivative of Growth Hormone-Releasing Hormone (GHRH) comprised of 44 amino acids. It is examined in laboratory settings for its capacity to promote natural growth hormone (GH) release and influence metabolic and fat-breakdown processes. This freeze-dried preparation is intended for investigational applications in controlled research facilities studying hormonal signaling, cellular proliferation mechanisms, and metabolic control.

Product Details

• Physical state: Freeze-dried powder
• Storage requirements: Keep vial in a cool, dry location. Following reconstitution, store solution at 2°C–8°C.
• Dissolution: Compatible with sterile water or bacteriostatic water.

Research Context

Tesamorlin is employed in scientific studies to examine:

• GH/IGF-1 pathway stimulation
• Fat metabolism and adipose tissue regulation
• Cellular repair and protein production control
• Hypothalamic-pituitary communication mechanisms

Important Notices

• Purpose: This peptide is supplied exclusively for in vitro laboratory research applications. It is not designed for human consumption or any form of application, including therapeutic, cosmetic, or nutritional purposes.
• Regulatory Notice: This compound has not received assessment from the U.S. Food and Drug Administration (FDA). No product or information provided is meant to diagnose, treat, cure, or prevent any medical condition. Usage is restricted to research facilities or qualified professionals functioning within lawful and ethical research parameters.
• Purchase Agreement: All sales through Kairos Research Labs are final. By completing a purchase, the buyer confirms they are a qualified researcher or laboratory professional possessing the suitable expertise to safely manage research peptides. Accountability for regulatory adherence, storage protocols, and proper usage rests entirely with the buyer.